“treatment resistant depression”的搜索结果，显示 111-120 项，共有 7708 项

1. 血液科- 临床试验- 妙佑医疗国际

   Tafasitamab, Lenalidomide And Venetoclax For The Treatment Of Relapsed Or Refractory Mantle Cell Lymphoma. Rochester, Minn. The purpose of this study is to ...

2. Mayo Clinic Digestive Diseases Physician Update - September 2023

   Page 1.

3. 血液科- 临床试验- 妙佑医疗国际

   Tafasitamab, Lenalidomide And Venetoclax For The Treatment Of Relapsed Or Refractory Mantle Cell Lymphoma. Rochester, Minn. The purpose of this study is to ...

4. 外科 - 临床试验- 妙佑医疗国际

   A Study Of Acute Stimulation For The Modulation Of Epileptic Events With A Closed-Loop Brain Interchange System In Drug Resistant Epilepsy. Rochester, Minn ...

5. 肾病和高血压- 临床试验- 妙佑医疗国际

   Post Approval Study for Treatment of Drug-resistant Adult Primary FSGS Using the LIPOSORBER® LA-15 System. Rochester, Minn., Jacksonville, Fla. The purpose ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... therapy and compare it to the biopsy performed prior to cancer treatment. ... Study of Tumor-treating Fields to Treat ... depression and anxiety. It has also been ...

7. 肺癌计划- 临床试验- 妙佑医疗国际

   The purpose of this study is to assess the safety and tolerability of escalating intratumoral doses of mRNA-2752 in participants with relapsed/refractory solid ...

8. 血液科- 临床试验- 妙佑医疗国际

   ... resistant to therapy. These activities are a first step toward identifying alternative therapies and subsequently beginning to personalize the therapy for ...

9. 血液科- 临床试验- 妙佑医疗国际

   ... resistant to therapy. These activities are a first step toward identifying alternative therapies and subsequently beginning to personalize the therapy for ...

10. 血液科- 临床试验- 妙佑医疗国际

    ... resistant to therapy. These activities are a first step toward identifying alternative therapies and subsequently beginning to personalize the therapy for ...